NeuBase Therapeutics (NBSE) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 82 253 sessions, May 24, 2023 to May 24, 2024
- Largest daily move
- +107% close of September 6, 2023
- 1-year change
- -90.5% closing prices, May 24, 2023 to May 24, 2024
- 1-month change
- -10.2% closing prices, April 24, 2024 to May 24, 2024
Company Description
NeuBase Therapeutics (NASDAQ: NBSE) is classified in the pharmaceutical preparations industry.
NBSE declined 90.5% in the 12 months to May 24, 2024. The last closing price was $0.3780.
This page collects what Stock Titan holds for NBSE, including price data and latest news.
Stock Performance
NeuBase Therapeutics (NBSE) closed at $0.3780 on May 24, 2024. In the 12 months to May 24, 2024, the price lost 90.5%.
NBSE Metrics & Rankings
Price returns through May 24, 2024. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
NeuBase Therapeutics has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include acquisition, private placement, offering, stock split, conferences. View all NBSE news →
SEC Filings
NBSE Company Profile & Sector Positioning
NeuBase Therapeutics (NBSE) and is listed on the NASDAQ.